Table 2. The area under the receiver operator curve for the discrimination between benign and malignant lesions for ADNEX with and without CA125 according to type of centre and sonographer.
|
ADNEX with CA125 |
ADNEX without CA125 |
|||
|---|---|---|---|---|
| Subgroup | AUC | 95% CI | AUC | 95% CI |
| All patients | 0.937 | 0.915–0.954 | 0.925 | 0.902–0.943 |
| Centre | ||||
| QCCH | 0.942 | 0.913–0.962 | 0.931 | 0.900–0.953 |
| PAH | 0.900 | 0.841–0.938 | 0.889 | 0.828–0.930 |
| GNH | 0.990 | 0.959–0.998 | 0.983 | 0.950–0.995 |
| Operator profession | ||||
| MD | 0.939 | 0.917–0.956 | 0.924 | 0.900–0.943 |
| Sonographer | 0.912 | 0.809–0.962 | 0.916 | 0.818–0.964 |
| Menopausal status | ||||
| Premenopausal | 0.939 | 0.901–0.963 | 0.935 | 0.901–0.958 |
| Postmenopausal | 0.899 | 0.855–0.931 | 0.873 | 0.824–0.910 |
Abbreviations: ADNEX=The Assessment of Different NEoplasias in the adneXa; AUC=area under the receiver operating curve; CA125=cancer antigen 125; CI=confidence interval; MD=medically qualified doctor; QCCH=Queen Charlotte's and Chelsea Hospital; PAH=Princess Anne Hospital; GNH=Garibaldi Nesima Hospital.